UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns

PloS one, 2017-11, Vol.12 (11), p.e0187893-e0187893

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial

Frontiers in immunology, 2021-11, Vol.12, p.767370-767370

2021

Link zum Volltext

Verfügbarkeit prüfen

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.19246-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Uso de metanfetamina en el contexto chemsex y sus consecuencias en la salud mental: Un estudio descriptivo

Revista española de salud pública, 2021 (95)

2021

Link zum Volltext

Verfügbarkeit prüfen

Overview of SARS-CoV-2 infection in adults living with HIV

The lancet HIV, 2021-05, Vol.8 (5), p.e294-e305

2021

Link zum Volltext

Verfügbarkeit prüfen

Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study

Infectious diseases and therapy, 2023-08, Vol.12 (8), p.2179-2189

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome

International journal of infectious diseases, 2021-03, Vol.104, p.164-168

2021

Link zum Volltext

Verfügbarkeit prüfen

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

The Lancet infectious diseases, 2015-07, Vol.15 (7), p.785-792

2015

Link zum Volltext

Verfügbarkeit prüfen

Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands

International journal of epidemiology, 2023-08, Vol.52 (4), p.e241-e252

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

Journal of antimicrobial chemotherapy, 2022-07, Vol.77 (8), p.2265-2273

2022

Link zum Volltext

Verfügbarkeit prüfen

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

Journal of antimicrobial chemotherapy, 2023-01, Vol.78 (1), p.108-116

2023

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis

Journal of antimicrobial chemotherapy, 2017-10, Vol.72 (10), p.2857-2861

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project

HIV medicine, 2024-04, Vol.25 (4), p.424-439

2024

Link zum Volltext

Verfügbarkeit prüfen

A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1987-1993

2016

Link zum Volltext

Verfügbarkeit prüfen

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)

Open forum infectious diseases, 2023-08, Vol.10 (8), p.ofad374-ofad374

2023

Link zum Volltext

Verfügbarkeit prüfen

A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1982-1986

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data

Infectious diseases and therapy, 2022-02, Vol.11 (1), p.1-13

2022

Link zum Volltext

Verfügbarkeit prüfen

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

AIDS (London), 2010-01, Vol.24 (3), p.F1-F9

2010

Link zum Volltext

Verfügbarkeit prüfen

Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience

Infectious diseases and therapy, 2023-02, Vol.12 (2), p.425-442

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.1133-1139

2022

Link zum Volltext

Verfügbarkeit prüfen

An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide–induced cholestasis

Antiviral therapy, 2021-01, Vol.26 (1-2), p.9-12

2021

Link zum Volltext

Verfügbarkeit prüfen

Tolerability of integrase inhibitors in a real-life setting

Journal of antimicrobial chemotherapy, 2017-06, Vol.72 (6), p.1752-1759

2017

Link zum Volltext

Verfügbarkeit prüfen

Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study

Journal of antimicrobial chemotherapy, 2022-06, Vol.77 (7), p.1974-1979

2022

Link zum Volltext

Verfügbarkeit prüfen

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e607-e612

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(79)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation

Uso de metanfetamina en el contexto chemsex y sus consecuencias en la salud mental: Un estudio descriptivo

Overview of SARS-CoV-2 infection in adults living with HIV

Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study

Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis

Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project

A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)

A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience

Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre

An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide–induced cholestasis

Tolerability of integrase inhibitors in a real-life setting

Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Suchergebnisse filtern